TABLE 1

Patients with Suspected Insulinoma Who Underwent Both Carbidopa-Assisted 18F-DOPA and 68Ga-DOTATOC PET/CT

Patient no. Age (y) Sex 24-h fast test Medical treatment CT/MRI EUSEarly/delayed 18F-DOPA/SSTR PET/CT Final diagnosis Gold standard
162FPositiveDiazoxide+/+, head+, head+/+/+, headInsulinoma, 10-mm, grade 1, Ki-67: 2%Pathology (surgery)
231FDoubtfulDiazoxide−/−?, body−/−/−Insulinoma excludedConsensus
316FPositiveDiazoxide−/−−/−/−Insulinoma excludedConsensus
470MPositiveDiazoxide+/+, tail+/+/+, tailNonfunctioning pNET, 66-mm, grade 3, Ki-67: 25%Pathology (surgery)
519FPositive−/−−/−/−Insulinoma excludedConsensus
662FPositive+/NA, body+, body−/−/+, bodyInsulinoma, 17-mmPathology (FNAB)
771FDoubtful−/NA+/+/+, headInsulinoma, 18-mm, grade 1, Ki-67: 1%Pathology (surgery)
877FDoubtful−/−?, tail−/−/−Insulinoma excludedConsensus
965MPositive−/−+, body−/−/−MiNEN, 10-mm, grade 1 (IHC: 15% insulin-positive, 90% SST-positive)Pathology (surgery)
1048FPositive+/+, tail+/+/+, tailInsulinoma, 17-mm, grade 1, Ki-67: 1%Pathology (surgery)
1178FPositiveDiazoxide+/NA, tail−/−/−Insulinoma, 12-mm, grade 1, Ki-67: 2%Pathology (surgery)
1264FPositive−/−−/−/−Insulinoma excludedConsensus
1327FDoubtful+/+, head+/−/+, headInsulinoma, 10-mm (MRI)Consensus
1464MDoubtful−/−−/−/−Insulinoma excludedConsensus
1578FDoubtful−/NA−/−/−Insulinoma excludedConsensus
1629FPositive−/+, tail+/+/−, tailInsulinoma, 12-mm, grade 1, Ki-67: 1%Pathology (surgery)
1767FPositiveDiazoxide−/−−/−/−Insulinoma (occult)Consensus
1864FDoubtful−/+, body+, body−/−/−Nonfunctioning pNET, 5-mm, grade 1, Ki-67: 1%Pathology (FNAB)
1972MPositiveDiazoxide+/NA, head+−/−/+, headInsulinoma, 10-mmPathology (FNAB)
2093MPositiveDiazoxide+/NA, tail−/−/+, tailInsulinoma, 13-mmConsensus
2152MPositiveNA/+, head+, head−/−/−Insulinoma, 22-mmPathology (FNAB)
  • EUS = endoscopic ultrasound; + = positive result; − = negative result; ? = doubtful result; pNET = pancreatic neuroendocrine tumor; NA = not available; FNAB = fine-needle aspiration biopsy; MiNEN = mixed neuroendocrine–nonneuroendocrine neoplasm; IHC = immunohistochemistry.